Systemic lupus erythematosus in men: A retrospective analysis in a veterans administration healthcare system population

Journal of Clinical Rheumatology

Volumn 7, Issue 3, 2001, Pages 142-150

  Prete, Pamela E ^a   Majlessi, Azadeh ^a   Gilman, Stuart ^a   Hamideh, Fayad ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Male lupus; Mortality; Racial distribution; Systemic lupus erythematosus

Indexed keywords

ADULT; AGE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE SYSTEM; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOLDIER; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE;

EID: 0034983663     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/00124743-200106000-00003     Document Type: Article

References (55)

1. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68: 353-5.
2. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991;21: 55-64.
3. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994;330: 1871-9.
4. Golan DT, Gilhar A, Pick IS, Weiss C, Bentwitch Z. [A longitudinal clinical study and laboratory survey of systemic lupus erythematosus]. Harefuah 1980;98: 241-4.
5. Dubois EL. Lupus erythematosus. 2nd ed. Los Angeles: University of Southern California Press, 1976: 232-437.
6. Fisher LD, van Belle G, editors. Biostatistics: a methodology for the health sciences. New York: John Wiley & Sons, 1993.
7. Brown F. ICD-9-CM Coding Handbook. 1999 Revised ed. Chicago: American Hospital Association Press, 1999.
8. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985;64: 285-95.
9. Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Baltimore) 1983;62: 327-34.
10. Deesomchok U, Tumrasvin T. Clinical features of systemic lupus erythematosus in Thai males and females. J Med Assoc Thai 1992;75: 133-40.
11. Costallat LT, Coimbra AM. Systemic lupus erythematosus in 18 Brazilian males: clinical and laboratory analysis. Clin Rheumatol 1993;12: 522-5.
12. Ward MM, Studenski S. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990;17: 220-4.
13. Masi AT, Kaslow RA. Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum 1978;21: 480-4.
14. Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum 1982;25: 55-60.
15. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50: 85-95.
16. Sthoeger ZM, Geltner D, Rider A, Bentwich Z. Systemic lupus erythematosus in 49 Israeli males: a retrospective study. Clin Exp Rheumatol 1987;5: 233-40.
17. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL. Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA 1981;245: 934-8.
18. Wilson HA, Hamilton ME, Spyker DA, Brunner CM, O’Brien WM, Davis JS IV, et al. Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum 1981;24: 1230-5.
19. Gilliam JN, Sontheimer RD. Subacute cutaneous lupus erythematosus. Clin Rheum Dis 1982;8: 343-52.
20. Arnett FC, Shulman LE. Studies in familial systemic lupus erythematosus. Medicine (Baltimore) 1976;55: 313-22.
21. Maddison PJ, Provost TT, Reichlin M. Serological findings in patients with “ANA-negative” systemic lupus erythematosus. Medicine (Baltimore) 1981;60: 87-94.
22. Batchelor JR, Welsh KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, et al. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1980;1: 1107-9.
23. Blomgren SE, Condemi JJ, Vaughan JH. Procainamide-induced lupus erythematosus. Clinical and laboratory observations. Am J Med 1972;52: 338-48.
24. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythematosu. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum 1970;13: 802-11.
25. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973;3: 1-54.
26. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974;134: 1027-35.
27. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995;38: 1260-70.
28. Baker SB, Rovira JR, Campion EW, Mills JA. Late onset systemic lupus erythematosus. Am J Med 1979;66: 727-32.
29. Foad BS, Sheon RP, Kirsner AB. Systemic lupus erythematosus in the elderly. Arch Intern Med 1972;130: 743-6.
30. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38: 551-8.
31. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991;50: 490-2.
32. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 1985;24: 147-54.
33. Jonsson H, Nived O, Sturfelt G, Silman A. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 1990;29: 185-8.
34. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 1990;17: 1162-7.
35. Greenwood BM. Autoimmune disease and parasitic infections in Nigerians. Lancet 1968;2: 380-2.
36. Jacyk WK, Damisah M. Discoid lupus erythematosus in the Nigerians. Br J Dermatol 1979;100: 131-5.
37. Taylor HG, Stein CM. Systemic lupus erythematosus in Zimbabwe. Ann Rheum Dis 1986;45: 645-8.
38. Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic PD. Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 1989;18: 189-97.
39. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982;25: 601-11.
40. Blum A, Rubinow A, Galun E. Predominance of renal involvement in male patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991;9: 206-7.
41. Chang CC, Shih TY, Chu SJ, Kuo SY, Chen CM, Hsu CM, et al. Lupus in Chinese male: a retrospective study of 61 patients. Chung Hua I Hsueh Tsa Chih (Taipei) 1995;55: 143-50.
42. Folomeev M, Alekberova Z. Survival pattern of 120 males with systemic lupus erythematosus. J Rheumatol 1990;17: 856-9.
43. Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) 1996;75: 124-30.
44. Specker C, Becker A, Lakomek HJ, Bach D, Grabensee B. Systemic lupus erythematosus in men-a different prognosis? Z Rheumatol 1994;53: 339-45.
45. Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983;75: 382-91.
46. Baldwin DS, Lowenstein J, Rothfield NF, Gallo G, McCluskey RT. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med 1970;73: 929-42.
47. Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994;23: 547-54.
48. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989;68: 141-50.
49. Donadio JV Jr, Torres VE, Velosa JA, Wagoner RD, Holley KE, Okamura M, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988;33: 708-15.
50. Hopper J Jr, Trew PA, Biava CG. Membranous nephropathy: its relative benignity in women. Nephron 1981;29: 18-24.
51. Blanco FJ, Gomez-Reino JJ, de la Mata J, Corrales A, Rodriguez-Valverde V, Rosas JC, et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998;7: 159-63.
52. Swaak AJ, Nossent JC, Bronsveld W, van Rooyen A, Nieuwenhuys EJ, Theuns L, et al. Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989;48: 455-60.
53. Pande I, Malaviya AN, Sekharan NG, Kailash S, Uppal SS, Kumar A. SLE in Indian men: analysis of the clinical and laboratory features with a review of the literature. Lupus 1994;3: 181-6.
54. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38: 274-83.
55. Rubin LA, Urowitz MB, Gladman DL. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985;55: 87-98.